SCU was consistently losing money with the Lantene operation. Several hundred thousand dollars in losses each and every quarter.
- Forums
- ASX - By Stock
- Ann: Completion of acquisition of Foshan Gedishi Biotechnology Co
SCU was consistently losing money with the Lantene operation....
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BP8 (ASX) to my watchlist